217 related articles for article (PubMed ID: 11174845)
1. Hormonal interactions in endometrial cancer.
Emons G; Fleckenstein G; Hinney B; Huschmand A; Heyl W
Endocr Relat Cancer; 2000 Dec; 7(4):227-42. PubMed ID: 11174845
[TBL] [Abstract][Full Text] [Related]
2. Hormonal heterogeneity of endometrial cancer.
Gründker C; Günthert AR; Emons G
Adv Exp Med Biol; 2008; 630():166-88. PubMed ID: 18637491
[TBL] [Abstract][Full Text] [Related]
3. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
Gambrell RD; Bagnell CA; Greenblatt RB
Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
[TBL] [Abstract][Full Text] [Related]
4. Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics.
Audet-Walsh E; Lépine J; Grégoire J; Plante M; Caron P; Têtu B; Ayotte P; Brisson J; Villeneuve L; Bélanger A; Guillemette C
J Clin Endocrinol Metab; 2011 Feb; 96(2):E330-9. PubMed ID: 21147881
[TBL] [Abstract][Full Text] [Related]
5. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
[TBL] [Abstract][Full Text] [Related]
6. Hormonal pathology of the endometrium.
Deligdisch L
Mod Pathol; 2000 Mar; 13(3):285-94. PubMed ID: 10757339
[TBL] [Abstract][Full Text] [Related]
7. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
8. Biological roles of estrogen and progesterone in human endometrial carcinoma--new developments in potential endocrine therapy for endometrial cancer.
Ito K; Utsunomiya H; Yaegashi N; Sasano H
Endocr J; 2007 Dec; 54(5):667-79. PubMed ID: 17785917
[TBL] [Abstract][Full Text] [Related]
9. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
Horn LC; Meinel A; Handzel R; Einenkel J
Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
[TBL] [Abstract][Full Text] [Related]
10. The Role of KRAS in Endometrial Cancer: A Mini-Review.
Sideris M; Emin EI; Abdullah Z; Hanrahan J; Stefatou KM; Sevas V; Emin E; Hollingworth T; Odejinmi F; Papagrigoriadis S; Vimplis S; Willmott F
Anticancer Res; 2019 Feb; 39(2):533-539. PubMed ID: 30711927
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
Wild MJ; Rudland PS; Back DJ
J Steroid Biochem Mol Biol; 1993 May; 45(5):407-20. PubMed ID: 8499348
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and cancers: the biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast.
Ito K
Tohoku J Exp Med; 2007 May; 212(1):1-12. PubMed ID: 17464097
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and endometrial cancer.
Emons G; Huschmand-Nia A; Krauss T; Hinney B
Onkologie; 2004 Apr; 27(2):207-10. PubMed ID: 15138357
[TBL] [Abstract][Full Text] [Related]
14. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
Schmidt D; Horn LC
Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
[TBL] [Abstract][Full Text] [Related]
15. [Environmental and genetic risk factors for endometrial carcinoma].
Sénéchal C; Cottereau E; de Pauw A; Elan C; Dagousset I; Fourchotte V; Gauthier-Villars M; Lae M; Stoppa-Lyonnet D; Buecher B
Bull Cancer; 2015 Mar; 102(3):256-69. PubMed ID: 25725922
[TBL] [Abstract][Full Text] [Related]
16. Endometrial carcinoma in elderly women.
Hoffman K; Nekhlyudov L; Deligdisch L
Gynecol Oncol; 1995 Aug; 58(2):198-201. PubMed ID: 7622105
[TBL] [Abstract][Full Text] [Related]
17. Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones.
Hale GE; Hughes CL; Cline JM
J Clin Endocrinol Metab; 2002 Jan; 87(1):3-15. PubMed ID: 11788613
[No Abstract] [Full Text] [Related]
18. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
19. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen therapy for breast cancer and endometrial cancer risk.
Bernstein L; Deapen D; Cerhan JR; Schwartz SM; Liff J; McGann-Maloney E; Perlman JA; Ford L
J Natl Cancer Inst; 1999 Oct; 91(19):1654-62. PubMed ID: 10511593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
